BARBATO, EMANUELE

BARBATO, EMANUELE  

Dipartimento di Scienze biomediche avanzate  

Mostra records
Risultati 1 - 20 di 332 (tempo di esecuzione: 0.028 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Insulin modulation of an endothelial nitric oxide component present in the alfa2-and beta-adrenergic responses in human forearm 1.1 Articolo in rivista 1997 Lembo, G; Iaccarino, G; Vecchione, C; Barbato, Emanuele; Izzo, Raffaele; Fontana, D; Trimarco, Bruno
The THR164ILE polymorphism of the beta 2 adrenergic receptor (AR) gene affects the rate and the outcome of severe coronary artery disease (CAD). 1.5 Abstract in rivista 2002 Galasso, Gennaro; Iaccarino, G; Piscione, F; Cipolletta, E; Marrazzo, G; Lanni, F; Trimarco, Valentina; Barbato, Emanuele; Chiariello, M; Trimarco, Bruno
Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting. 1.1 Articolo in rivista 2011 Puymirat, E; Mangiacapra, F; Peace, A; Sharif, F; Conte, M; Bartunek, J; Vanderheyden, M; Wijns, W; de Bruyne, B; Barbato, Emanuele
Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus. 1.1 Articolo in rivista 2014 Mangiacapra, F; Peace, A; Barbato, Emanuele; Patti, G; Gatto, L; Ricottini, E; De Bruyne, B; Di Sciascio, G; Wijns, W.
Transcatheter aortic valve replacement in patients with aortic stenosis and left ventricular dysfunction: patient selection counts more than ever! 1.1 Articolo in rivista 2013 Barbato, Emanuele; Wijns, W.
ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation. 1.1 Articolo in rivista 2014 Pyxaras, Sa; Mangiacapra, F; Wijns, W; Di Serafino, L; De Vroey, F; Toth, G; Sinagra, G; De Bruyne, B; Heyndrickx, Gr; Barbato, Emanuele
Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial. 1.1 Articolo in rivista 2014 Barbato, Emanuele; Herman, A; Benit, E; Janssens, L; Lalmand, J; Hoffer, E; Chenu, P; Gu?d?s, A; Missault, L; Pirenne, B; Cardinal, F; Vercauteren, S; Wijns, W.
Quantitative assessment of the coronary microvasculature: new tools for the black box. 1.1 Articolo in rivista 2013 De Bruyne, B; Barbato, Emanuele
Percutaneous revascularization strategies in small-vessel disease. 1.1 Articolo in rivista 2014 Puymirat, E; Barbato, Emanuele
A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study. 1.1 Articolo in rivista 2014 Barbato, Emanuele; Salinger Martinovic, S; Sagic, D; Beleslin, B; Vrolix, M; Neskovic, An; Jagic, N; Verheye, S; Mehmedbegovic, Z; Wijns, W.
Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. 1.1 Articolo in rivista 2014 Legrand, V; Cuisset, T; Chenu, P; Vrolix, M; Martinez, C; Dens, J; Gach, O; Boland, J; Claeys, Mj; Magne, J; Barbato, Emanuele; Wijns, W.
Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. 1.1 Articolo in rivista 2013 Fearon, Wf; Shilane, D; Pijls, Nh; Boothroyd, Db; Tonino, Pa; Barbato, Emanuele; J?ni, P; De Bruyne, B; Hlatky, Ma; Fractional Flow Reserve Versus Angiography for Multivessel Evaluation, 2 Investigators
High cholesterol levels are associated with coronary microvascular dysfunction. 1.1 Articolo in rivista 2012 Mangiacapra, F; De Bruyne, B; Peace, Aj; Melikian, N; Wijns, W; Barbato, Emanuele
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial). 1.1 Articolo in rivista 2013 Patti, G; Pasceri, V; Mangiacapra, F; Colonna, G; Vizzi, V; Ricottini, E; Montinaro, A; D'Ambrosio, A; Wijns, W; Barbato, Emanuele; Di Sciascio, G; Armyda, 8 RELOAD ACS Investigators
St. John's Wort in patients non-responders to clopidogrel undergoing percutaneous coronary intervention: a single-center randomized open-label trial (St. John's Trial). 1.1 Articolo in rivista 2013 Trana, C; Toth, G; Wijns, W; Barbato, Emanuele
Impact of alpha- and Beta-adrenergic receptor blockers on fractional flow reserve and index of microvascular resistance. 1.1 Articolo in rivista 2014 Barbato, Emanuele; Sarno, G; Berza, Ct; Di Gioia, G; Bartunek, J; Vanderheyden, M; Di Serafino, L; Wijns, W; Trimarco, Bruno; De Bruyne, B.
The C2238 Atrial Natriuretic Peptide Molecular Variant is Associated with Endothelial Damage and Dysfunction Through Natriuretic Peptide Receptor C Signaling. 1.1 Articolo in rivista 2013 Sciarretta, S; Marchitti, Ss; Bianchi, F; Moyes, A; Barbato, Emanuele; Di Castro, S; Stanzione, R; Cotugno, M; Castello, L; Calvieri, C; Eberini, I; Sadoshima, J; Hobbs, Aj; Volpe, M; Rubattu, S.
Letter by Mangiacapra and Barbato regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease". 1.1 Articolo in rivista 2013 Mangiacapra, F; Barbato, Emanuele
The role of fractional flow reserve to guide stent implantation. 1.1 Articolo in rivista 2011 Mangiacapra, F; Di Serafino, L; Barbato, Emanuele
Monocyte-platelets aggregates as cellular biomarker of endothelium-dependent coronary vasomotor dysfunction in patients with coronary artery disease. 1.1 Articolo in rivista 2014 Di Serafino, L; Sarma, J; Dierickx, K; Ntarladimas, I; Pyxaras, Sa; Delrue, L; De Bruyne, B; Wijns, W; Barbato, Emanuele; Bartunek, J.